BCAX
Bicara Therapeutics Inc.
$16.25
-$0.21(-1.28%)
53
Overall
60
Value
66
Tech
34
Quality
Market Cap
$932.48M
Volume
538.59K
52W Range
$7.80 - $28.09
Target Price
$32.14
EPS Estimates Overview
| Current Quarter | $-0.55 | Next Quarter | $-0.6 |
| Current Year | $-2.32 | Next Year | $-2.71 |
| QoQ Growth | -9.1% | YoY Growth | -16.8% |
| 3Y EPS CAGR | N/A | Target Price | $32.14 |
| Consensus | Buy | Upside | +97.8% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCAX | $16.25 | -1.3% | 538.59K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bicara Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW